Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTH | AMGN | VRTX | REGN | GILD |
| Company | Cyclo Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.2000 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 1.3400 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 1.1201 | 332.47 | 491.52 | 1,064.95 | 72.02 |
| Last | 1.1600 | 334.67 | 495.76 | 1,073.32 | 72.18 |
| Change | -0.0500 | +3.38 | +4.19 | +9.72 | -0.38 |
| % Change | -4.13% | +1.02% | +0.85% | +0.91% | -0.52% |
| Volume | 314,865 | 678,372 | 457,926 | 110,057 | 1,649,555 |
| 20-Day Average Volume | 40,447 | 2,033,940 | 1,113,405 | 416,284 | 6,313,927 |
| Previous Close | 1.2100 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2455 | 320.96 | 481.86 | 1,064.46 | 69.78 |
| 20-Day Raw Stochastic | 17.86% | 86.72% | 88.40% | 63.51% | 71.72% |
| 20-Day Relative Strength | 43.48% | 67.82% | 67.23% | 58.27% | 62.62% |
| Weighted Alpha | -41.08 | +41.30 | +43.95 | +42.69 | -4.82 |
| Today's Opinion | 96% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.50% since 07/15/24 | +1.35% since 07/15/24 | +0.84% since 07/15/24 | -0.96% since 07/15/24 | +2.25% since 07/15/24 |
| Low | 1.1200 on 07/22/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 1.3400 on 07/22/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | -10.00% since 06/21/24 | +8.58% since 06/21/24 | +5.60% since 06/21/24 | +1.76% since 06/21/24 | +2.45% since 06/21/24 |
| Low | 1.1200 on 07/22/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 1.3999 on 07/11/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | -7.14% since 04/22/24 | +23.06% since 04/22/24 | +23.77% since 04/22/24 | +19.05% since 04/22/24 | +8.14% since 04/22/24 |
| Low | 1.1100 on 06/05/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.6199 on 05/06/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | -31.18% since 01/22/24 | +7.88% since 01/22/24 | +12.47% since 01/22/24 | +13.67% since 01/22/24 | -7.69% since 01/22/24 |
| Low | 1.1000 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 2.1150 on 01/26/24 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,625 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 28,616 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 1,080,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -20,060,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 200,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -4,340,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | -0.33 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 05/15/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/20/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |